Skip to main content

SARS-CoV-2 Variant Inhibitor Screening Kit

COVID-19
Now with Omincron and Delta Variant!

Get 50% off! Use Promo Code: CoV2Kit50
(3)
Data showing blocking ability of antibodies from vaccinated individuals to disrupt the Spike protein to ACE-2 interaction in ELISA

Key Product Details

Assay Type: ELISA Type Binding Assay
Sample Types: Cell Lysates
SARS-CoV-2 Variant Inhibitor Screening Kit Features:

See the Data: Read our white paper on testing individual serum samples using this kit. Download White Paper

 

Assay Workflow: 5 Simple Steps

 

Product Features

  • Quickly and efficiently evaluates the effectiveness of vaccines against SARS-CoV-2 variants
  • Can be used for high throughput screening SARS-CoV-2 inhibitors
  • Validated step by step assay protocol
  • No special equipment needed

Background: Severe acute respiratory syndrome Coronavirus-2

Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19, has posed a serious threat to global human health. With the emergence of variants, especially the Variants of Concern (VOCs), a quick and effective way to assess how effective the current vaccines are against the major variants is needed. The COVID-19 Neutralization Kit is an ELISA type of binding assay measuring the ability of the sera of vaccinated donors to block the binding between RBDs of COVID-19 variants and human ACE-2.

 

Complete Your Research

Citations for SARS-CoV-2 Variant Inhibitor Screening Kit

View all citations for the ELISA Kits platform.
Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

Product Documents

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.